MKC.V compared with PDSB: revenue, margins and what each company keeps, and the suppliers and customers both name

MKC.VMcCormick & Co., Inc.

Mkt capRevenueRevenue

PDSBPDS Biotechnology Corp

Mkt capRevenueRevenue

Compare

MKC.VMcCormick & Co., Inc.

PDSBPDS Biotechnology Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

PDSB: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MKC.V 0

None

Shared 0

No disclosed counterparties: MKC.V.

Only PDSB 2

MRKMerckcustomer

—NCIunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

MKC.V, solidPDSB, dashed

MKC.VMcCormick & Co., Inc.

51.18· pre 50.00· delayed

Mkt cap$12.9BRevenue$2.0BQ3 FY26Revenue$6.8BFY25

PDSBPDS Biotechnology Corp

1.29· pre 1.30· delayed

Pre-marketNov 5 '26delayed

Mkt cap$78.9MRevenue—Revenue—

Compare

Pre-marketNov 5 '26delayed

MKC.VMcCormick & Co., Inc.

PDSBPDS Biotechnology Corp

51.18pre 50.00delayed

Price

1.29pre 1.30delayed

$12.9B

Mkt cap

$78.9M

Q3 FY26$2.0B

Revenue

—

FY25$6.8B

Revenue

—

MKC.V51.18vsPDSB1.29Pre-marketNov 5 '26delayed